Evolent Health Revenue 2014-2026 | EVH
Evolent Health revenue from 2014 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Evolent Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $1,876 |
| 2024 | $2,555 |
| 2023 | $1,964 |
| 2022 | $1,352 |
| 2021 | $908 |
| 2020 | $925 |
| 2019 | $687 |
| 2018 | $627 |
| 2017 | $435 |
| 2016 | $254 |
| 2015 | $97 |
| 2013 | $26 |
|
Evolent Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-06-30 | $653 |
| 2026-03-31 | $496 |
| 2025-12-31 | $469 |
| 2025-09-30 | $480 |
| 2025-06-30 | $444 |
| 2025-03-31 | $484 |
| 2024-12-31 | $647 |
| 2024-09-30 | $621 |
| 2024-06-30 | $647 |
| 2024-03-31 | $640 |
| 2023-12-31 | $556 |
| 2023-09-30 | $511 |
| 2023-06-30 | $469 |
| 2023-03-31 | $428 |
| 2022-12-31 | $382 |
| 2022-09-30 | $353 |
| 2022-06-30 | $320 |
| 2022-03-31 | $297 |
| 2021-12-31 | $248 |
| 2021-09-30 | $222 |
| 2021-06-30 | $222 |
| 2021-03-31 | $215 |
| 2020-12-31 | $247 |
| 2020-09-30 | $240 |
| 2020-06-30 | $217 |
| 2020-03-31 | $221 |
| 2019-12-31 | $77 |
| 2019-09-30 | $220 |
| 2019-06-30 | $192 |
| 2019-03-31 | $198 |
| 2018-12-31 | $193 |
| 2018-09-30 | $150 |
| 2018-06-30 | $144 |
| 2018-03-31 | $140 |
| 2017-12-31 | $114 |
| 2017-09-30 | $108 |
| 2017-06-30 | $107 |
| 2017-03-31 | $106 |
| 2016-12-31 | $88 |
| 2016-09-30 | $60 |
| 2016-06-30 | $57 |
| 2016-03-31 | $49 |
| 2015-12-31 | $46 |
| 2015-09-30 | $40 |
| 2015-06-30 | $10 |
| 2014-12-31 | $-20 |
| 2014-03-31 | $20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.464B | $1.876B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |